These genes (JCHAIN and CD79A) were reported to be lower expressed altogether in colorectal carcinoma and in others non-squamous cell carcinoma by Pan J. et al. (2021), suggesting a potential indicator for immunotherapy. This evidence concerns the gene CD79A and squamous cell carcinoma.